Geode Capital Management, LLC Synaptogenix, Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Synaptogenix, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 154,471 shares of SNPX stock, worth $633,331. This represents 0.0% of its overall portfolio holdings.
Number of Shares
154,471
Previous 154,471
-0.0%
Holding current value
$633,331
Previous $41,000
29.27%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SNPX
# of Institutions
25Shares Held
955KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny401KShares$1.64 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il83.5KShares$342,5300.0% of portfolio
-
Two Sigma Securities, LLC New York, NY83.4KShares$341,9760.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA68.5KShares$280,9400.0% of portfolio
-
Cannell & Co. New York, NY30KShares$122,9990.0% of portfolio
About Synaptogenix, Inc.
- Ticker SNPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 6,840,630
- Market Cap $28M
- Description
- Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...